Advertisement

Topics

Lenabasum Showing Promise in Systemic Scleroderma

11:50 EDT 14 Jun 2018 | Medscape

The oral, synthetic, nonimmunosuppressive small molecule improves outcome scores for patients with few treatment options, new research shows.
Medscape Medical News

Original Article: Lenabasum Showing Promise in Systemic Scleroderma

NEXT ARTICLE

More From BioPortfolio on "Lenabasum Showing Promise in Systemic Scleroderma"

Advertisement
Quick Search
Advertisement
Advertisement